Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-109
Closed -$12.7K 193
2024
Q4
$12.7K Buy
+109
New +$15.7K ﹤0.01% 203
2022
Q3
Sell
-8,292
Closed -$866K 118
2022
Q2
$866K Sell
8,292
-463
-5% -$62.7K 0.21% 64
2022
Q1
$1.3M Sell
8,755
-2,589
-23% -$318K 0.29% 50
2021
Q4
$1.29M Sell
11,344
-536
-5% -$58.6K 0.31% 47
2021
Q3
$1.17M Buy
11,880
+799
+7% +$84.9K 0.28% 60
2021
Q2
$1.06M Buy
+11,081
New +$1.04M 0.26% 70
2020
Q1
Sell
-504
Closed -$28K 360
2019
Q4
$28K Hold
504
0.01% 230
2019
Q3
$26K Hold
504
0.01% 230
2019
Q2
$28K Hold
504
0.01% 234
2019
Q1
$29K Hold
504
0.01% 212
2018
Q4
$26K Buy
+504
New +$29.8K 0.01% 225

Other funds holding NUE

Human Investing's NUE Position: Q1 2025 in Review

Human Investing sold out of Nucor (NUE) in Q1 2025, closing a stake of 109 shares — an estimated $12.7K sold.

Human Investing first reported a position in NUE in Q4 2018 and held it in 11 quarters. The position peaked at $1.3M in Q1 2022. 1,181 funds tracked by Wall St. Rank hold NUE as of Q1 2025.

  • Human Investing reported no remaining Nucor position as of Q1 2025 after selling out during the quarter.
  • Human Investing sold 109 Nucor shares in Q1 2025, an estimated $12.7K.
  • Human Investing first reported a position in Nucor in Q4 2018 and held it in 11 quarters.
  • Human Investing's Nucor position peaked at $1.3M in Q1 2022.
  • 1,181 funds tracked by Wall St. Rank held Nucor as of Q1 2025.

Based on Human Investing's 13F filing for Q1 2025, filed 15 May 2025.